The AXL positivity rate of the CellSearch® CTC‐AXL assay was defined as the ratio between the number of AXL+ cancer cells detected by the CellTracks analyzer and the initial 100 cancer cells (Figure 2A,B). This evidence concerns the gene AXL and cancer.